Trends in mortality of liver cancer before and during the <scp>COVID</scp>‐19 pandemic, 2017–2021
Donghee Kim(Chungnam National University), Aijaz Ahmed(Stanford University), Richie Manikat(Stanford University), George Cholankeril(Baylor College of Medicine)
Cited by 8
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
|World Journal of Hepatology|2017|183
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Nonalcoholic fatty liver disease and non-liver comorbidities
|Clinical and Molecular Hepatology|2023|37